久久久国产一区二区_欧美在线小视频_高清一区二区三区_久久综合久久久_成人久久久久久久久_亚洲精品视

上海非利加實(shí)業(yè)有限公司Logo

熱門(mén)詞: 進(jìn)口電動(dòng)溫度調(diào)節(jié)閥結(jié)構(gòu)圖|進(jìn)口電動(dòng)溫度調(diào)節(jié)閥數(shù)據(jù)表進(jìn)口電動(dòng)高溫調(diào)節(jié)閥-德國(guó)進(jìn)口電動(dòng)高溫法蘭調(diào)節(jié)閥進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥-德國(guó)進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥

當(dāng)前位置: 首頁(yè) > 所有品牌 > VaxInnate
VaxInnate
VaxInnate VaxInnate

美國(guó)VaxInnate
VaxInnate公司是一家私人持有的生物技術(shù)公司,開(kāi)發(fā)新穎,專有疫苗為大流行病和季節(jié)性流感。該公司的突破疫苗是基于其Toll樣受體( TLR為)的技術(shù)平臺(tái),大大提高了疫苗的免疫原性和有效性。利用TLR為技術(shù),疫苗可產(chǎn)生的簡(jiǎn)單,低成本,高可擴(kuò)展性重組DNA技術(shù),避免許多挑戰(zhàn)和隱患的雞蛋或細(xì)胞培養(yǎng)流感疫苗的生產(chǎn)。 VaxInnate的技術(shù)有可能顯著提高成本效益,制造能力和效力的流感疫苗-面臨的關(guān)鍵問(wèn)題的臨床和公共健康的社區(qū)。

美國(guó)生物制藥公司VaxInnate總裁艾倫·肖在接受新華社記者采訪時(shí)表示,針對(duì)這種新型病毒(豬流感病毒)的疫苗樣品有望在4周內(nèi)研制成功。

VaxInnate is a privately-held biotechnology company developing novel, proprietary vaccines for both pandemic and seasonal influenza. The company's breakthrough vaccines are based on its Toll-like receptor (TLR) technology platform, which dramatically improves vaccine immunogenicity and efficacy. Using the TLR technology, vaccines can be produced by simple, low-cost, highly-scalable recombinant DNA techniques, avoiding many of the challenges and pitfalls of egg-based or cell-culture influenza vaccine production. VaxInnate's technology has the potential to significantly improve the cost-effectiveness, manufacturing capacity, and potency of influenza vaccines - key issues facing the clinical and public health communities.

 

VaxInnate has a BSL2+ laboratory operational within the Cranbury site, and also has access to BSL-2 vivarium space through a collaborative research agreement with Yale University . VaxInnate also has a collaborative arrangement with an academic institution for access to high level biocontainment facilities (BSL-3 and -4). Since avian influenza requires BSL-3 or -4 facilities, depending on the strain in question, this access enables the VaxInnate to conduct live virus challenges in animal models.



VaxInnate was founded by Ruslan Medzhitov and Richard Flavell, both of Yale University and Howard Hughes Medical Institute and leaders in the field of innate immunity. The company started in 2002 with Michael Sherman serving as Chief Executive Officer and a research team in New Haven , CT. In 2004, the company expanded and established a development team and corporate headquarters in Cranbury , NJ . The company currently has approximately 58 employees including 18 with doctoral degrees.

 

Currently, VaxInnate occupies approximately 30,000 square feet of laboratory and office space in Cranbury , NJ , and New Haven , CT. This includes molecular and cell biology labs, cell culture facilities, a protein pilot plant and analytical laboratory space.

 

VaxInnate has raised more than $64 million to date and is backed by well-known venture capital firms, including HealthCare Ventures, Oxford Bioscience Partners LLC, MedImmune Ventures, Inc., CHL Medical Partners, New Leaf Venture Partners, and Canaan Partners.


關(guān)于我們客戶服務(wù)產(chǎn)品分類法律聲明
主站蜘蛛池模板: 亚洲欧洲精品一区二区三区 | 亚洲伊人国产 | 国产淫语打电话对白在线播放 | 久久成人国产精品二三区 | 久久精品成人国产午夜 | 国产日产欧美精品一区二区三区 | 欧美午夜在线观看 | 99精品在免费线视频 | 一区高清 | 性新婚a大黄毛片 | 一级毛片私人影院免费 | 日本一区二区三区高清在线观看 | 欧美国产精品va在线观看 | 久久久国产精品视频 | 欧美日韩精品一区二区三区视频在线 | 亚洲欧美国产精品专区久久 | 国产亚洲一区二区三区不卡 | 免费在线观看中文字幕 | 中国亲与子乱αy | 欧美日韩不卡视频一区二区三区 | 日韩www视频 | 欧美视频二区 | 精品国产一区二区三区19 | 欧美骚| 国产一区二区三区成人久久片 | 91久久精品国产免费一区 | 中文字幕日韩有码 | 日韩欧美中文 | 在线国产日韩 | 91久久精品国产亚洲 | 欧美日韩高清一区 | 欧美高清亚洲欧美一区h | 成人国产精品久久久免费 | 欧美精品日韩 | 91香蕉国产亚洲一区二区三区 | 一级毛片特黄久久免费看 | 免费亚洲网站 | 亚洲电影网址 | 国产亚洲一区二区三区在线 | 精品视频在线观看视频免费视频 | 国内精品伊人久久大香线焦 |